Dr. John Hays on Gynecologic Cancer Mutations and Choosing the Right Treatment

John Hays, MD

Hays says current genetic testing gives oncologists a wide variety of information that may make choosing the correct treatment "a little more difficult." Hays adds that within the current treatment paradigm of gynecologic cancer, oncologists are mainly focusing on BRCA mutations.

John Hays, MD, assistant professor, Internal Medicine, College of Medicine, Ohio State University, discusses the plethora of genetic mutation information oncologists have when it comes to treating gynecologic cancers. Hays says current genetic testing gives oncologists a wide variety of information that may make choosing the correct treatment "a little more difficult." Hays adds that within the current treatment paradigm of gynecologic cancer, oncologists are mainly focusing on BRCA mutations.